GI & Endoscopy

Here are the five most read gastroenterology/endoscopy stories for Dec. 19 to Dec. 23, 2016.

Henry Levine, MD, is a gastroenterologist and the founder of the Orlando-based Center for Digestive Health.

Researchers from the United Kingdom have developed a blood-based test for bowel cancer that has 97 percent accuracy, Wales Online reports.

Ivan Friedrich, MD, is a gastroenterologist with the Englewood Cliffs-based Gastroenterology Group of Northern New Jersey.

The American Gastroenterological Society created its Clinical Observation and Research Education program with the goal of bringing young international physicians to the U.S. to expose them to research opportunities and clinical observations.

Cedar Valley, Pa.-based Olympus received FDA 510(k) clearance of claims for its Endocuff endoscopic device.

Jerry Vandeveer is a bell ringer for the Salvation Army in Fort Wayne, Ind., but located next to his donation bucket is a sign asking donors "Have you had a colonoscopy?" WANE reports.

Bridgewater, N.J.-based Clinical Genomics, a biotechnology company focused on colorectal cancer diagnosis, has appointed Mark Boyle to president of in vitro diagnostics.

Japan's Takeda Pharmaceuticals is exercising its option to develop and commercialize Leuven, Belgium-based TiGenix's Cx601 in Canada and Japan.

A study in Cancer Prevention Research claims that vitamin E and selenium do not prevent colorectal adenomas, UPI reports.